Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma
Condition(s):Carcinoma, Renal CellLast Updated:May 27, 2009Completed
Hide Studies Not Open or Pending
Condition(s):Carcinoma, Renal CellLast Updated:May 27, 2009Completed
Condition(s):Renal Cell CarcinomaLast Updated:April 25, 2018Completed
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:April 26, 2018Completed
Condition(s):Renal Cell CarcinomaLast Updated:April 19, 2022Unknown status
Condition(s):Renal Carcinoma; Renal Cell Carcinoma; Urothelial CarcinomaLast Updated:March 19, 2024Not yet recruiting
Condition(s):Metastatic Renal Cell Carcinoma; Kidney CancerLast Updated:November 11, 2008Completed
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:January 8, 2019Terminated
Condition(s):Renal Cell CarcinomaLast Updated:October 2, 2018Unknown status
Condition(s):Kidney CancerLast Updated:July 12, 2018Terminated
Condition(s):Renal Cell CarcinomaLast Updated:December 6, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.